One-stop-platform for plant-based nutraceuticals
In 2020, nutra brands will look to ensure they have plant-based options across all product classes with many actively looking to move entire portfolios plant-based.
Ahead of SupplySide West, Sirio Pharma unveils full spectrum of one-stop-services for all plant-based products and announces plans for 2020.
The company is using the event to actively promote its integrated solutions in plant-based nutraceuticals. Sirio offers plant-based solutions across all dosage form platforms. The Sirio Group is able to rapidly develop customer products across the entire spectrum of delivery formats – including gummies, softgels, and tablets. The company also offers organic softgels at Ayanda’s European site – a Sirio Group company – with plans underway to get organic certification across all sites.
“What you see in the wider market are some contract providers across formats such as tablets and softgels working on plant-based solutions here and there. Sirio is leading the market delivering plant-based solutions across all delivery formats – gummies, softgels, tablets, powders and liquids. Sirio has a wide range of capabilities and, just as crucially, experience formulating these compounds for customers globally,” said Doug Brown, Director Americas at Sirio Pharma.
The company anticipates that many customers, particularly those in North America and Europe, are now looking at ways to move their entire product portfolios across to plant-based solutions and using one contract provider presents a good number of advantages.
Brown added: “Sirio presents a one-stop-shop for plant-based product solutions. It is strategically important that customers transitioning entire lines to plant-based formats know that there is a trusted, experienced partner in Sirio that can deliver end-to-end development, formulation and manufacturing services for them delivered anywhere in the world on time and in full.”
The company’s plant-based one-stop-services focus at SupplySide West mark the start of an extended push to global customers, with Sirio also introducing the platform to European customers at CPHI Worldwide in November.
Sirio anticipates that while the plant-based movement has been building for a number of years, 2020 will be the year that companies look to ensure they have plant-based options across all product classes.
Significantly, this will have implications for the capabilities needed from CDMO partners. Sirio entered this market early on with its patented technologies for softgels and pectin-based gummies. With many new customized products potentially needed, the company predicts an extremely large demand for full-service plant-based capabilities.
Related News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Women in Pharma: Minding the Gap at Pharmapack 2024
2024 marks the first year Pharmapack will host a Diversity track dedicated to bridging the gap within the pharmaceutical packaging and drug delivery sector. The track includes a panel discussion on 'Enabling Diversity in the Workplace,' focused... -
News Pharmapack Awards 2024 - Celebrating Packaging and Drug Delivery Innovation
The 2024 Pharmapack Innovation Awards ceremony celebrated the best in pharmaceutical packaging and drug delivery innovation at all levels. The awards were held on January 24, 2024 at the Paris Expo Porte de Versailles. -
News Pharmapack 2024 - From the Floor
Paris once again welcomes Europe’s leading trade show in pharmaceutical packaging and drug delivery innovation. Join our content team as Pharmapack 2024 opens its doors to leading experts and innovators in pharmaceutical packaging and drug delive... -
News CPHI Barcelona 2023: Partnering for Success – Managing Outsourcing Relationships to Optimise Manufacturing Operations
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most. -
News CPHI Barcelona 2023: Loading Potential – Artificial Intelligence for Pharma Manufacturing
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most. -
News Pharmaceutical industry supports COP28 health stance in joint statement
As COP28 takes place over this week in Dubai, UAE, several bodies in the pharmaceutical and health industries have come together to announce support of key movements in sustainability in the sector, and to recognise sustainability as a health issue.&nb... -
News CPHI Podcast Series: Start-ups take centre stage at CPHI Barcelona
The first episode of the CPHI Podcast Series since we attended CPHI Barcelona in October covers the Start-up market at the event, with expert Matthew Wise joining Editor Lucy Chard to discuss the event.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance